5.70
Koru Medical Systems Inc stock is traded at $5.70, with a volume of 215.46K.
It is up +2.15% in the last 24 hours and down -1.72% over the past month.
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).
See More
Previous Close:
$5.58
Open:
$5.6
24h Volume:
215.46K
Relative Volume:
1.37
Market Cap:
$264.04M
Revenue:
$33.65M
Net Income/Loss:
$-6.07M
P/E Ratio:
-47.50
EPS:
-0.12
Net Cash Flow:
$-1.66M
1W Performance:
+2.33%
1M Performance:
-1.72%
6M Performance:
+64.74%
1Y Performance:
+37.68%
Koru Medical Systems Inc Stock (KRMD) Company Profile
Name
Koru Medical Systems Inc
Sector
Industry
Phone
845-469-2042
Address
100 CORPORATE DRIVE, MAHWAH, NY
Compare KRMD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
KRMD
Koru Medical Systems Inc
|
5.70 | 258.48M | 33.65M | -6.07M | -1.66M | -0.12 |
|
ISRG
Intuitive Surgical Inc
|
523.69 | 186.98B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
206.18 | 57.95B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
81.62 | 38.83B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
259.28 | 36.96B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
MDLN
Medline Inc
|
43.30 | 36.74B | 27.43B | 1.27B | 1.01B | 1.5829 |
Koru Medical Systems Inc Stock (KRMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-14-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jul-25-24 | Resumed | B. Riley Securities | Buy |
| Sep-07-23 | Initiated | B. Riley Securities | Buy |
| Sep-07-23 | Initiated | Lake Street | Buy |
| Nov-10-22 | Upgrade | Canaccord Genuity | Hold → Buy |
| Nov-10-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jan-26-21 | Downgrade | Canaccord Genuity | Buy → Hold |
| Jan-26-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-10-20 | Initiated | H.C. Wainwright | Buy |
| Jul-16-20 | Initiated | Canaccord Genuity | Buy |
| Jun-24-20 | Initiated | Piper Sandler | Overweight |
View All
Koru Medical Systems Inc Stock (KRMD) Latest News
All You Need to Know About KORU Medical Systems, Inc. (KRMD) Rating Upgrade to Buy - Yahoo Finance
Stock Recap: Does KORU Medical Systems Inc meet Warren Buffetts criteria2025 Technical Overview & Weekly High Conviction Trade Ideas - baoquankhu1.vn
Bearish Setup: Is KORU Medical Systems Inc impacted by rising ratesWeekly Trading Summary & Weekly Market Pulse Alerts - baoquankhu1.vn
Head to Head Analysis: Patient Portal Technologies (OTCMKTS:PPRG) & KORU Medical Systems (NASDAQ:KRMD) - Defense World
Will KORU Medical Systems Inc. stock gain from strong economyWeekly Profit Summary & Daily Growth Stock Tips - bollywoodhelpline.com
How is KORU Medical Systems Inc managing supply chain issues2025 Market Trends & Low Risk Growth Stock Ideas - baoquankhu1.vn
Moving Averages: How sensitive is KORU Medical Systems Inc to inflationWeekly Profit Summary & Risk Managed Trade Strategies - baoquankhu1.vn
KORU Medical Systems, Inc. (NASDAQ:KRMD) Receives $5.88 Consensus Target Price from Brokerages - Defense World
KORU Medical reports 23% revenue growth in Q4 2025 By Investing.com - Investing.com Canada
Guidance Update: Is KORU Medical Systems Inc stock showing strong momentumWall Street Watch & Long-Term Safe Investment Ideas - baoquankhu1.vn
Koru Medical (KRMD) Exceeds Revenue Expectations for FY25 - GuruFocus
KORU Medical Systems Reports Preliminary Q4 and Full Year 2025 Results; Achieves Record Revenue and Full Year Positive Operating Cash Flow - marketscreener.com
Wall Street Zen Upgrades KORU Medical Systems (NASDAQ:KRMD) to “Strong-Buy” - Defense World
Wall Street Zen Upgrades KORU Medical Systems (NASDAQ:KRMD) to "Strong-Buy" - MarketBeat
KORU Medical Systems, Inc. (NASDAQ:KRMD) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Will KORU Medical Systems Inc. stock outperform growth indexes2025 Price Targets & Fast Exit/Entry Strategy Plans - ulpravda.ru
Aug Spikes: Why analysts upgrade KORU Medical Systems Inc. stockProduct Launch & Technical Pattern Alert System - ulpravda.ru
Will KORU Medical Systems Inc. stock split attract more investorsPerformance Line Overview & HOKA model picks for your routine - Улправда
3 MedTech Stocks That Crushed the S&P 500 Over the Past Year - Finviz
US Stocks Recap: Can KORU Medical Systems Inc. stock sustain revenue growthJuly 2025 Momentum & AI Powered Buy/Sell Recommendations - Улправда
Jobs Data: Will KORU Medical Systems Inc. stock split attract more investors2025 Earnings Surprises & Growth Focused Entry Reports - Улправда
Why KORU Medical Systems Inc. stock could outperform in 2025 - Улправда
US Market Wrap: Will KORU Medical Systems Inc. stock gain from strong economyGap Up & Low Risk High Reward Ideas - Улправда
KRMD submits 510(k) to use FreedomEDGE system with oncology biologic - MSN
KORU Medical Systems announces inducement grant - Medical Buyer
KORU Medical Systems Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Chartmill
KORU Medical Systems (NASDAQ:KRMD) Rating Lowered to Buy at Wall Street Zen - MarketBeat
What drives KORU Medical Systems Inc stock priceMarket Sentiment Extremes & Watch Expert Picks Before They Rally - earlytimes.in
KORU Medical Systems (KRMD) registers stock and options for incoming CTO - Stock Titan
KORU Medical seeks FDA clearance for infusion system - MSN
KRMD Submits 510(k) to Use FreedomEDGE System With Oncology Biologic - The Globe and Mail
Koru Medical submits FreedomEDGE 510(k) premarket notification to the FDA - MSN
KORU Medical Systems (KRMD) FDA Approvals, PDUFA Dates & Drug Alerts 2026 - MarketBeat
Analyzing Movano (NASDAQ:MOVE) and KORU Medical Systems (NASDAQ:KRMD) - Defense World
KORU Medical submits FDA application for breast cancer therapy device By Investing.com - Investing.com Nigeria
Koru Medical Systems announces 510(k) submission for clearance of FreedomEdge system with a commercialized oncology biologic - marketscreener.com
KORU Seeks FDA Clearance for Drug Delivery System - marketscreener.com
Koru Medical (KRMD) Seeks FDA Clearance for New Use of Infusion System - GuruFocus
KORU Medical submits FDA application for breast cancer therapy device - Investing.com
KORU Medical Systems Announces 510(k) Submission for Clearance of the FreedomEDGE® System with a Commercialized Oncology Biologic - Yahoo Finance
Albion Financial Group UT Sells 140,000 Shares of KORU Medical Systems, Inc. $KRMD - Defense World
Weekly Trades: Will KORU Medical Systems Inc stock split attract more investorsJuly 2025 Earnings & Real-Time Market Sentiment Reports - Bộ Nội Vụ
KORU Medical Systems (NASDAQ:KRMD) Rating Increased to Strong-Buy at Wall Street Zen - MarketBeat
Can KORU Medical Systems Sustain Its Momentum After Hitting A 52-Week High? - RTTNews
KRMD: Lake Street Raises Price Target; Maintains Buy Rating | KR - GuruFocus
Here's Why You Should Retain INSP Stock in Your Portfolio Now - Finviz
Can KORU Medical Systems Inc. stock reach $100 price targetJuly 2025 EndofMonth & Growth Focused Entry Point Reports - Улправда
Will KORU Medical Systems Inc. stock benefit from green energy trends2025 Growth vs Value & Reliable Entry Point Alerts - Улправда
Why analysts upgrade KORU Medical Systems Inc. stockEquity Performance Review & These Stocks Are Just Getting Started - bollywoodhelpline.com
Will KORU Medical Systems Inc. stock benefit from AI adoptionTrade Analysis Report & Long-Term Capital Growth Ideas - Улправда
Can KORU Medical Systems Inc. stock withstand economic slowdownQuarterly Profit Review & Daily Profit Focused Screening - Улправда
Koru Medical Systems Inc Stock (KRMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):